CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - China
t, has released its latest report, CountryFocus: ...
Reasons to buy
This report will enhance your decision-making capability by allowing you to -
- Develop business strategies...
4.2.1 Overview Of Regulatory Agencies 146
4.2.2 New Drug Approval Process 148
4.2.3 Generic Drug Approval Process 150
4.2....
5.7.1 China Chamber Of Commerce For Import And Export Of Medicines And Health Products 236
5.7.2 China Healthcare Associat...
Upcoming SlideShare
Loading in …5
×

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - China:Latest Industry Size Research Report

185 views

Published on

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - China@http://www.researchmoz.us/countryfocus-healthcare-regulatory-and-reimbursement-landscape-china-report.html

Published in: Business, Health & Medicine
0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total views
185
On SlideShare
0
From Embeds
0
Number of Embeds
1
Actions
Shares
0
Downloads
2
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - China:Latest Industry Size Research Report

  1. 1. CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - China t, has released its latest report, CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - China. The report is an essential source of information and analysis on the healthcare, regulatory and reimbursement landscape in China. It identifies the key trends in the healthcare market and provides insights into the demographic, regulatory, reimbursement landscape and healthcare infrastructure. Most importantly, the report provides valuable insights into the trends and segmentation of the pharmaceutical and medical device markets. It is built using data and information sourced from proprietary databases, secondary research, and in-house analysis by GlobalDatas team of industry experts. China is the most populated country in the world. In 2012, its population was approximately 1.3 billion, approximately one fifth of the global population. Growth has however been effectively controlled and has slowed down due to the strict enforcement of family-planning and one-child policies. The decline in the size of the young working-age group and the growing elderly population are however matters of concern for policy planners. Chinas pharmaceutical industry was estimated to be worth $287 billion in 2012. The market for western medicine was approximately $8.8 billion in 2007 and was estimated at $46.7 billion in 2012. The medical device market was worth approximately $20.1 billion in 2012 and is expected to reach approximately $53.5 billion by 2020 at a projected Compound Annual Growth Rate (CAGR) of 13.1%. These positive trends can primarily be attributed to - - Increasingly elderly population - Widening healthcare insurance coverage - Improved Intellectual Property Rights (IPR) environment Scope The report provides information on the healthcare, regulatory and reimbursement landscape in China, and includes - - Overview of the pharmaceutical and medical devices markets, comprising market size, segmentation, and key drivers and barriers - Profiles and SWOT analysis of the major players in the pharmaceutical market, of which the major Multinational Companies (MNCs) were GlaxoSmithKline (GSK), Pfizer, and AstraZeneca; and the major domestic players were Harbin Pharmaceutical Group and Tasly Pharmaceutical Group; and the medical device market, of which the major players were Siemens Healthcare, GE Healthcare, Fresenius Medical Care, GlaxoSmithKline, and Philips Healthcare - Insightful review of the reimbursement and regulatory landscape, of which analysis includes details of the healthcare reimbursement process, regulatory agencies, and market authorization processes for new drugs and medical devices - Detailed analysis of the political and economic environment, covering economic indicators, demographics, healthcare infrastructure, and healthcare expenditure - An overview of the opportunities for and challenges to growth in the Chinese healthcare market CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - China
  2. 2. Reasons to buy This report will enhance your decision-making capability by allowing you to - - Develop business strategies by understanding the trends shaping and driving Chinas healthcare market - Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical and medical devices market segments, and companies likely to impact the healthcare market in the future - Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing the performance of various competitors - Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investments, and strategic partnerships - Identify, understand and capitalize on the opportunities and challenges in Chinas healthcare market 1 Table Of Contents 1 Table Of Contents 7 1.1 List Of Tables 10 1.2 List Of Figures 15 2 Introduction 19 2.1 Report Guidance 19 3 Overview Of The Pharmaceutical And Medical Device Markets 20 3.1 Pharmaceutical Market 20 3.1.1 Market Overview 20 3.1.2 Pharmaceutical Imports And Exports 24 3.1.3 Supply Channels 25 3.1.4 Market Segments 27 3.1.5 Major Disease Areas 34 3.1.6 Major Players 39 3.2 Medical Device Market 82 3.2.1 Market Overview 82 3.2.2 Overview Of Top Five Segments 84 3.2.3 Diagnostics Market 96 3.2.4 Major Players 98 3.3 Market Drivers And Barriers 132 3.3.1 Drivers 132 3.3.2 Barriers 134 4 Market Access 136 4.1 Reimbursement And Payer Landscape 136 4.1.1 Overview Of Healthcare System 136 4.1.2 Reimbursement Process 137 4.1.3 Overview Of Insurance Providers 142 4.1.4 Patient Share In Healthcare Spending 143 4.1.5 Healthcare Price Trends 144 4.1.6 Pricing Policies 145 4.2 Regulatory Landscape 146 CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - China
  3. 3. 4.2.1 Overview Of Regulatory Agencies 146 4.2.2 New Drug Approval Process 148 4.2.3 Generic Drug Approval Process 150 4.2.4 New Medical Device Approval Process 150 4.2.5 Licensing Process For Pharmaceutical And Medical Device Manufacturing 156 4.2.6 Licensing Process For Pharmaceutical Exports And Imports 157 4.2.7 Intellectual Property Rights 158 4.2.8 Clinical Trial Regulations 160 4.2.9 Pharmaceutical Advertising Regulations 162 4.2.10 Pharmacy Regulations 163 4.2.11 Labeling And Packaging Regulations 164 5 Country Analysis 166 5.1 Political Environment 166 5.1.1 Political Structure 166 5.1.2 Analysis Of Current Political Environment 167 5.1.3 Healthcare Policy Initiatives 168 5.2 Economic Landscape 170 5.3 Economic Indicators 173 5.3.1 Gross Domestic Product 173 5.3.2 Gross National Income 177 5.3.3 Inflation 178 5.3.4 Currency Exchange Rate 182 5.3.5 Foreign Direct Investment 183 5.3.6 Foreign Exchange Reserves 184 5.3.7 Trade Balance 185 5.3.8 Government Structural Balance 188 5.3.9 Government Gross Debt 190 5.3.10 Major Industries 191 5.4 Demographics 193 5.4.1 Population 193 5.4.2 Education And Literacy 209 5.4.3 Employment 211 5.4.4 Disease Burden 212 5.5 Healthcare Infrastructure 216 5.5.1 Healthcare Facilities 216 5.5.2 Healthcare Parameters 220 5.5.3 Environmental Health 222 5.5.4 Healthcare Personnel 230 5.6 Healthcare Expenditure 232 5.6.1 Overview 232 5.6.2 Major Components Of Healthcare Spending 233 5.6.3 Public And Private Sector Share 235 5.7 Trade Associations And Trade Fairs 236 CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - China
  4. 4. 5.7.1 China Chamber Of Commerce For Import And Export Of Medicines And Health Products 236 5.7.2 China Healthcare Association 236 5.7.3 Shanghai Medical Instrument Trade Association 236 5.7.4 Chinese Hospital Association 236 5.7.5 China Pharmaceutical Industry Association 237 5.8 Trade Fairs 237 6 Opportunities And Challenges 239 6.1 Opportunities 239 6.2 Challenges 240 7 Appendix 242 7.1 Abbreviations 242 7.2 Bibliography 245 7.3 Methodology 255 7.3.1 Coverage 256 7.3.2 Secondary Research 256 7.3.3 Forecasting 257 7.3.4 Expert Panel Validation 257 7.4 Disclaimer 257 ResearchMoz(http://www.researchmoz.us/) is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price. Contact: M/s Sheela, 90 State Street, Suite 700, Albany NY - 12207 United States Tel: +1-518-618-1030 USA - Canada Toll Free 866-997-4948 Email: sales@researchmoz.us Website: http://www.researchmoz.us/ CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - China

×